← Back to screener

Zura Bio Ltd ZURA

Rank #2024 · Nasdaq · $0.4B market cap
⚠ Going-concern flag — the auditor (WithumSmith+Brown, PC) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
36.0
P/E
-7.3
P/B
2.61
ROE
-35.7%
Op. Margin
–%
Debt Ratio
13%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E -7.3x, P/B 2.61x. Ranks in the top 66% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -35.7%. Ranks in the top 86% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 13%. Ranks in the top 11% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2021–––$0.0B––
2022–$-0.0B$0.0B$0.0B––
2023–$-0.1B$-0.0B$-0.0B–-46
2024–$-0.1B$-0.1B$0.1B–36
2025–$-0.1B$-0.1B$0.1B–13

← See the full screener